Granahan Investment Management LLC cut its stake in Silicon Laboratories, Inc. (NASDAQ:SLAB - Free Report) by 41.4% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 27,216 shares of the semiconductor company's stock after selling 19,247 shares during the quarter. Granahan Investment Management LLC owned 0.08% of Silicon Laboratories worth $3,064,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Quarry LP purchased a new stake in shares of Silicon Laboratories in the first quarter worth approximately $25,000. Skandinaviska Enskilda Banken AB publ purchased a new stake in shares of Silicon Laboratories during the first quarter valued at approximately $34,000. UMB Bank n.a. increased its position in shares of Silicon Laboratories by 111.3% during the first quarter. UMB Bank n.a. now owns 336 shares of the semiconductor company's stock valued at $38,000 after acquiring an additional 177 shares during the last quarter. Parallel Advisors LLC increased its position in shares of Silicon Laboratories by 143.7% during the first quarter. Parallel Advisors LLC now owns 463 shares of the semiconductor company's stock valued at $52,000 after acquiring an additional 273 shares during the last quarter. Finally, Larson Financial Group LLC purchased a new stake in shares of Silicon Laboratories during the first quarter valued at approximately $55,000.
Insiders Place Their Bets
In other Silicon Laboratories news, SVP Brandon Tolany sold 1,800 shares of the firm's stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $133.57, for a total transaction of $240,426.00. Following the sale, the senior vice president owned 62,328 shares in the company, valued at $8,325,150.96. This trade represents a 2.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders sold a total of 12,070 shares of company stock worth $1,703,472 in the last quarter. Company insiders own 1.60% of the company's stock.
Silicon Laboratories Stock Up 1.2%
Shares of NASDAQ:SLAB traded up $1.60 during midday trading on Thursday, reaching $133.82. 41,333 shares of the company traded hands, compared to its average volume of 394,490. Silicon Laboratories, Inc. has a 12 month low of $82.82 and a 12 month high of $160.00. The firm has a market capitalization of $4.39 billion, a price-to-earnings ratio of -41.58 and a beta of 1.52. The firm's fifty day moving average price is $136.52 and its two-hundred day moving average price is $126.61.
Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The semiconductor company reported $0.11 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.09 by $0.02. The company had revenue of $192.85 million for the quarter, compared to analyst estimates of $192.57 million. Silicon Laboratories had a negative return on equity of 7.21% and a negative net margin of 14.88%.The firm's revenue for the quarter was up 32.6% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.56) EPS. Silicon Laboratories has set its Q3 2025 guidance at 0.200-0.400 EPS. Analysts forecast that Silicon Laboratories, Inc. will post -0.97 earnings per share for the current year.
Analyst Upgrades and Downgrades
A number of brokerages recently commented on SLAB. Barclays increased their price target on Silicon Laboratories from $100.00 to $130.00 and gave the company an "equal weight" rating in a research report on Tuesday, August 5th. Morgan Stanley decreased their price target on Silicon Laboratories from $157.00 to $144.00 and set an "equal weight" rating for the company in a research report on Wednesday, August 6th. Wall Street Zen raised Silicon Laboratories from a "sell" rating to a "hold" rating in a research report on Wednesday, May 14th. Benchmark reaffirmed a "buy" rating and set a $160.00 price target on shares of Silicon Laboratories in a research report on Tuesday, May 27th. Finally, Needham & Company LLC reaffirmed a "buy" rating and set a $150.00 price target on shares of Silicon Laboratories in a research report on Wednesday, May 14th. Five research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $151.13.
Read Our Latest Research Report on SLAB
About Silicon Laboratories
(
Free Report)
Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
See Also

Before you consider Silicon Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Silicon Laboratories wasn't on the list.
While Silicon Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.